PAVM News and Press, PAVmed Inc.

Lucid Diagnostics to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference PR Newswire NEW YORK , April 8, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention...

2024-03-28 10:01:50 ET More on Health Care Select Sector SPDR XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run John...

2024-03-27 15:12:10 ET PAVmed Inc. (PAVM) Q4 2023 Earnings Conference Call March 27, 2024 08:30 ET Company Participants Dennis McGrath - Executive Vice President & Chief Financial Officer Lishan Aklog - Chairman & Chief Executive Officer Conference Call...

2024-03-27 00:53:53 ET More on PAVmed Seeking Alpha’s Quant Rating on PAVmed Historical earnings data for PAVmed Financial information for PAVmed Read the full article on Seeking Alpha For further details see: PAVmed Non-GAAP EPS of -$1.33 ...

PAVmed Provides Business Update and Fourth Quarter and Full Year 2023 Financial Results PR Newswire Lucid's quarterly revenue increased 33 percent sequentially Launched wholly-owned incubator, PMX, to complete development and commercialization of existing portfolio tec...

2024-03-26 12:11:19 ET More on PAVmed Seeking Alpha’s Quant Rating on PAVmed Historical earnings data for PAVmed Financial information for PAVmed Read the full article on Seeking Alpha For further details see: PAVmed Q4 2024 Earnings Preview

2024-03-26 09:51:41 ET Major earnings expected before the bell on Wednesday include: Altimmune ( ALT ) Carnival Corporation ( CCL ) Cintas ( CTAS ) Paychex ( PAYX ) Tsakos Energy Navigation ( TNP ) Read the full article on Seeking Alpha ...

Iochpe-Maxion S.A. ADR (IOCJY) is expected to report for quarter end 2023-12-31 The Alkaline Water Company Inc. (WTER) is expected to report for Q3 2024 Clover Leaf Capital Corp. (CLOE) is expected to report for Q4 2023 Silvergate Capital Corporation Class A (SICP) is expected to repo...

Lucid Diagnostics Announces Positive Data from the First Prospective Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening Population PR Newswire Prospective VA screening study demonstrates excellent EsoGuard sensitivity of 92.9% and negative ...

PAVmed Launches Incubator to Advance Existing Pipeline Technologies including PortIO, EsoCure and CarpX PR Newswire The incubator, PMX, and medical device firm Hatch Medical, execute joint venture agreement to complete their development and commercialization, starting with Por...